رجوع
نطاق اليوم
KWD 84.91
KWD 88.49
نطاق 52 أسبوعًا
KWD 81.36
KWD 118.30
حجم التداول
409,136
متوسط 50 يوم / 200 يوم
KWD 100.54
/
KWD 95.51
الإغلاق السابق
KWD 87.16
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 40.5 | 0.3 |
| P/B | 1.4 | 2.9 |
| ROE % | 3.2 | 3.7 |
| Net Margin % | 8.5 | 3.8 |
| Rev Growth 5Y % | -7.1 | 10.0 |
| D/E | 0.5 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 115.140
+31.6%
Low: KWD 105.000
High: KWD 129.000
مكرر الربحية المستقبلي
16.1
ربحية السهم المستقبلية
KWD 5.401
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 7.910
KWD 7.843 – KWD 8.009
|
3.7 B | 1 |
| FY2029 |
KWD 7.155
KWD 7.094 – KWD 7.245
|
3.5 B | 1 |
| FY2028 |
KWD 6.542
KWD 5.322 – KWD 7.762
|
3.3 B | 2 |
النقاط الرئيسية
Revenue declined -7.06% annually over 5 years
Earnings declined -18.31% over the past year
ROE of 3.24% is below average
Debt/Equity of 0.48 — conservative balance sheet
Generating 508.26M in free cash flow
P/E of 40.46 — premium valuation
النمو
Revenue Growth (5Y)
-7.06%
Revenue (1Y)3.67%
Earnings (1Y)-18.31%
FCF Growth (3Y)616.37%
الجودة
Return on Equity
3.24%
ROIC2.48%
Net Margin8.46%
Op. Margin12.49%
الأمان
Debt / Equity
0.48
Current Ratio1.68
Interest Coverage3.87
التقييم
P/E Ratio
40.46
P/B Ratio1.35
EV/EBITDA34.70
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.67% | Revenue Growth (3Y) | 1.90% |
| Earnings Growth (1Y) | -18.31% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -7.06% | Earnings Growth (5Y) | -28.85% |
| Profitability | |||
| Revenue (TTM) | 2.86B | Net Income (TTM) | 241.68M |
| ROE | 3.24% | ROA | 1.99% |
| Gross Margin | 53.08% | Operating Margin | 12.49% |
| Net Margin | 8.46% | Free Cash Flow (TTM) | 508.26M |
| ROIC | 2.48% | FCF Growth (3Y) | 616.37% |
| Safety | |||
| Debt / Equity | 0.48 | Current Ratio | 1.68 |
| Interest Coverage | 3.87 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 40.46 | P/B Ratio | 1.35 |
| P/S Ratio | 3.42 | PEG Ratio | -3.32 |
| EV/EBITDA | 34.70 | Dividend Yield | 0.00% |
| Market Cap | 9.78B | Enterprise Value | 12.37B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.86B | 2.76B | 2.75B | 3.31B | 3.83B |
| Net Income | 241.68M | 295.83M | -118.38M | 569.18M | 943.16M |
| EPS (Diluted) | 2.08 | 2.41 | -0.95 | 4.50 | 8.08 |
| Gross Profit | 1.52B | 1.32B | 1.32B | 1.76B | 2.28B |
| Operating Income | 356.64M | 410.52M | 399.49M | 781.12M | 1.34B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 12.17B | 12.39B | 13.56B | 14.13B | 15.00B |
| Total Liabilities | 4.92B | 4.73B | 5.69B | 6.75B | 7.86B |
| Shareholders' Equity | 7.25B | 7.67B | 7.87B | 7.38B | 7.14B |
| Total Debt | 3.52B | 3.33B | 4.07B | 4.60B | 5.16B |
| Cash & Equivalents | 919.87M | 1.16B | 913.16M | 454.36M | 603.32M |
| Current Assets | 2.24B | 2.35B | 3.00B | 3.29B | 2.44B |
| Current Liabilities | 1.33B | 653.10M | 1.45B | 1.54B | 1.21B |